title: Vitiligo: new and emerging treatments.
abstract: Vitiligo is a cosmetically disfiguring condition, and, although there is no therapeutic full solution yet, some treatment may induce good results in most patients. The disease can be successfully treated with various medical options. Both nonfocused or focused narrowband ultraviolet B phototherapy represents the current treatment of choice, to minimize side effects and reach optimal clinical results. Topical novel approaches are also considered. Surgical methods, consisting of autologous transplantation methods, is generally recommended for focal/stable vitiligo, after medical therapy has failed. Finally, for patients with extensive vitiligo, depigmentation of the residual melanin should be taken into account.
authors.affiliation: Department of Dermatological Sciences, University of Florence, Florence, Italy.
authors.forename: Torello
authors.initials: T
authors.lastname: Lotti
authors.forename: Alessia
authors.initials: A
authors.lastname: Gori
authors.forename: Fabio
authors.initials: F
authors.lastname: Zanieri
authors.forename: Roberta
authors.initials: R
authors.lastname: Colucci
authors.forename: Silvia
authors.initials: S
authors.lastname: Moretti
mesh_terms: D000287:Administration, Topical; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003880:Dermatology / Q000639:trends; D006801:Humans; D018579:Patient Selection; D012880:Skin Pigmentation / Q000187:drug effects / Q000528:radiation effects; D016038:Skin Transplantation / Q000639:trends; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000639:trends; D014820:Vitiligo / Q000188:drug therapy / Q000503:physiopathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
chemical_list: D000975:Antioxidants; D003879:Dermatologic Agents